Table 4.
Status | Tissue type | Control | Aberrant microRNA expression | Ref. |
Active CD | Peripheral blood, n = 14 | Healthy | Decreased: miR-149* and plus-F1065 | Wu et al[31], 2011 |
Increased: miR-199a-5p, 340*, 362-3p, 532-3p and plus-E1271 | ||||
Peripheral blood, n = 46 | Healthy | Increased: miR-16, 20a, 21, 30e, 93, 106a, 140, 192, 195, 484 and let-7b | Zahm et al[33], 2011 | |
Peripheral blood, n = 128 | Healthy | Increased: miR-16, 23a, 29a, 106a, 107, 126, 191, 199a-5p, 200c, 362-3p and 532-3p | Paraskevi et al[32], 2012 | |
Active and inactive CD | Peripheral blood, n = 18 | Healthy | Decreased: miR-877 | Iborra et al[25], 2013 |
Increased: miR-16, 27a*, 140-3p, 140-5p and 195 | ||||
Inactive CD | Peripheral blood, n = 5 | Healthy | Decreased: miR-149* | Wu et al[31], 2011 |
Increased: miR-340* | ||||
Active CD | Peripheral blood, n = 9 | Inactive CD | Decreased: miR-18a, 128, 140-5p and 145 | Iborra et al[25], 2013 |
Increased: miR-188-5p and 877 |
CD: Crohn’s disease; UC: Ulcerative colitis.